NRx Pharmaceuticals, Inc. NRXP
2.55 USD -0.25 (-8.93%)
Regular-session close
2.55 0.00 0.00%
After hours · Nov 19, 7:16 PM ET
2.52 Day range 2.88
1.62 52-week range 5.06
- YTD
- -5.90%
- 1 year
- +19.72%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.23M | 0 | 0 | 0 | 0 | |
| 720.00K | 0 | 0 | 0 | 0 | |
| -16.22M | -18.50M | -27.84M | -44.34M | -115.80M | |
| -28.62M | -25.13M | -30.15M | -39.75M | -93.06M | |
| -1.34 | -2.36 | -3.98 | -6.00 | -19.80 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 7.80M | 1.44M | 4.59M | 20.05M | 27.61M | |
| 12.96M | 3.65M | 7.32M | 25.82M | 32.73M | |
| 28.89M | 26.87M | 19.05M | 18.41M | 11.92M | |
| 631.00K | 6.58M | 9.16M | 10.53M | 518.00K | |
| -15.94M | -23.22M | -11.73M | 7.41M | 20.81M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -14.11M | -10.64M | -21.66M | -39.76M | -37.70M | |
| -2.81M | 0 | -3.00K | -10.00K | -7.00K | |
| 23.28M | 7.49M | 6.20M | 32.21M | 63.46M | |
| 6.35M | -3.15M | -15.46M | -7.55M | 25.75M |
